BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12915771)

  • 1. Association of interleukin-5 and eotaxin with acute exacerbation of asthma.
    Park SW; Kim DJ; Chang HS; Park SJ; Lee YM; Park JS; Chung IY; Lee JH; Park CS
    Int Arch Allergy Immunol; 2003 Aug; 131(4):283-90. PubMed ID: 12915771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
    Xu J; Jiang F; Nayeri F; Zetterström O
    Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eotaxin-2 in sputum cell culture to evaluate asthma inflammation.
    Scheicher ME; Teixeira MM; Cunha FQ; Teixeira AL; Filho JT; Vianna EO
    Eur Respir J; 2007 Mar; 29(3):489-95. PubMed ID: 17079258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum.
    Yamada H; Yamaguchi M; Yamamoto K; Nakajima T; Hirai K; Morita Y; Sano Y; Yamada H
    Allergy; 2000 Apr; 55(4):392-7. PubMed ID: 10782526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smoking affects eotaxin levels in asthma patients.
    Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
    J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrinsic defect in T cell production of interleukin (IL)-13 in the absence of both IL-5 and eotaxin precludes the development of eosinophilia and airways hyperreactivity in experimental asthma.
    Mattes J; Yang M; Mahalingam S; Kuehr J; Webb DC; Simson L; Hogan SP; Koskinen A; McKenzie AN; Dent LA; Rothenberg ME; Matthaei KI; Young IG; Foster PS
    J Exp Med; 2002 Jun; 195(11):1433-44. PubMed ID: 12045241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eotaxin level in induced sputum is increased in patients with bronchial asthma and in smokers.
    Yamamoto K; Takanashi S; Hasegawa Y; Kanehira Y; Kaizuka M; Okumura K
    Respiration; 2003; 70(6):600-5. PubMed ID: 14732790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation.
    Gauvreau GM; Watson RM; O'Byrne PM
    Am J Respir Crit Care Med; 1999 Aug; 160(2):640-7. PubMed ID: 10430741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CC chemokines and interleukin-5 in bronchial lavage fluid from patients with status asthmaticus. Potential implication in eosinophil recruitment.
    Tillie-Leblond I; Hammad H; Desurmont S; Pugin J; Wallaert B; Tonnel AB; Gosset P
    Am J Respir Crit Care Med; 2000 Aug; 162(2 Pt 1):586-92. PubMed ID: 10934091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism.
    Pope SM; Brandt EB; Mishra A; Hogan SP; Zimmermann N; Matthaei KI; Foster PS; Rothenberg ME
    J Allergy Clin Immunol; 2001 Oct; 108(4):594-601. PubMed ID: 11590387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of intranasal budesonide on allergen-induced production of interleukin-5 and eotaxin, airways, blood, and bone marrow eosinophilia, and eosinophil progenitor expansion in sensitized mice.
    Shen H; O'Byrne PM; Ellis R; Wattie J; Tang C; Inman MD
    Am J Respir Crit Care Med; 2002 Jul; 166(2):146-53. PubMed ID: 12119225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlation between CCL26 production by human bronchial epithelial cells and airway eosinophils: Involvement in patients with severe eosinophilic asthma.
    Larose MC; Chakir J; Archambault AS; Joubert P; Provost V; Laviolette M; Flamand N
    J Allergy Clin Immunol; 2015 Oct; 136(4):904-13. PubMed ID: 25936567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of eotaxin in induced sputum of atopic and nonatopic asthmatics.
    Zeibecoglou K; Ying S; Meng Q; Kay AB; Robinson DS; Papageorgiou N
    Allergy; 2000 Nov; 55(11):1042-8. PubMed ID: 11097314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of eotaxin-1 to eosinophil chemotactic activity of moderate and severe asthmatic sputum.
    Dent G; Hadjicharalambous C; Yoshikawa T; Handy RL; Powell J; Anderson IK; Louis R; Davies DE; Djukanovic R
    Am J Respir Crit Care Med; 2004 May; 169(10):1110-7. PubMed ID: 15001461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asthma and natural colds. Inflammatory indices in induced sputum: a feasibility study.
    Pizzichini MM; Pizzichini E; Efthimiadis A; Chauhan AJ; Johnston SL; Hussack P; Mahony J; Dolovich J; Hargreave FE
    Am J Respir Crit Care Med; 1998 Oct; 158(4):1178-84. PubMed ID: 9769279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The roles of a Th2 cytokine and CC chemokine in children with stable asthma: potential implication in eosinophil degranulation.
    Kim CK; Kita H; Callaway Z; Kim HB; Choi J; Fujisawa T; Shin BM; Koh YY
    Pediatr Allergy Immunol; 2010 Jun; 21(4 Pt 2):e697-704. PubMed ID: 20444156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated levels of eotaxin and interleukin-5 in blister fluid of bullous pemphigoid: correlation with tissue eosinophilia.
    Wakugawa M; Nakamura K; Hino H; Toyama K; Hattori N; Okochi H; Yamada H; Hirai K; Tamaki K; Furue M
    Br J Dermatol; 2000 Jul; 143(1):112-6. PubMed ID: 10886144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion.
    Nonaka M; Fukumoto A; Ozu C; Mokuno E; Baba S; Pawankar R; Yagi T
    Acta Otolaryngol; 2003 Apr; 123(3):383-7. PubMed ID: 12737295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
    Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
    Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.